Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Epigenetic Modifications and Metabolic Rewiring as Targets for Cancer Therapy
Published on: October 18, 2024
Aberrant Activity of Histone-Lysine N-Methyltransferase 2 (KMT2) Complexes in Oncogenesis
Elzbieta Poreba1, Krzysztof Lesniewicz2, Julia Durzynska1
1Institute of Experimental Biology, Faculty of Biology, Adam Mickiewicz University, ul. Uniwersytetu Poznańskiego 6, 61-614 Poznań, Poland.
Abstract:
KMT2 (histone-lysine N-methyltransferase subclass 2) complexes methylate lysine 4 on the histone H3 tail at gene promoters and gene enhancers and, thus, control the process of gene transcription. These complexes not only play an essential role in normal development but have also been described as involved in the aberrant growth of tissues. KMT2 mutations resulting from the rearrangements of the KMT2A (MLL1) gene at 11q23 are associated with pediatric mixed-lineage leukemias, and recent studies demonstrate that KMT2 genes are frequently mutated in many types of human cancers. Moreover, other components of the KMT2 complexes have been reported to contribute to oncogenesis. This review summarizes the recent advances in our knowledge of the role of KMT2 complexes in cell transformation. In addition, it discusses the therapeutic targeting of different components of the KMT2 complexes.
Insights
Histone-lysine N-methyltransferase (KMT2) complexes regulate gene transcription and development. Aberrant KMT2 gene activity drives cancer, prompting research into targeted therapies for KMT2-related malignancies.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Biology
Background:
- KMT2 complexes regulate gene transcription via histone methylation at promoters and enhancers.
- These complexes are crucial for normal development but implicated in aberrant tissue growth.
- KMT2 gene mutations, particularly KMT2A (MLL1) rearrangements, are linked to pediatric leukemias and various cancers.
Purpose of the Study:
- To review recent advancements in understanding the role of KMT2 complexes in cell transformation.
- To discuss potential therapeutic strategies targeting KMT2 complex components.
Main Methods:
- Literature review of recent studies on KMT2 complexes in cancer.
- Analysis of the role of KMT2 components in oncogenesis.
- Summary of therapeutic targeting approaches.
Main Results:
- KMT2 complexes are frequently mutated in human cancers, contributing to oncogenesis.
- Components of KMT2 complexes play a role in cancer development.
- KMT2 mutations are associated with specific cancer types, including pediatric leukemias.
Conclusions:
- KMT2 complexes are critical regulators of gene transcription with significant roles in both normal development and cancer.
- Dysregulation of KMT2 complexes contributes to cell transformation and oncogenesis.
- Targeting KMT2 complex components represents a promising therapeutic avenue for KMT2-driven cancers.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification

